CEF20, Cytomegalovirus, CMV pp65 (495-503) - 1 mg
- Cat.Number : AS-28328
- Manufacturer Ref. :
-
Availability :
In production
HLA-A*0201-restricted epitope from Cytomegalovirus pp65 (495-503).
Specifications
| Chemistry | |
| Sequence one letter code |
|
|---|---|
| Sequence three letter code |
|
| CAS registry number |
|
| Molecular Formula |
|
| Molecular Mass/ Weight |
|
| Modification | |
| Conjugation |
|
| Quantity & Purity | |
| Purity |
|
| Storage & stability | |
| Form |
|
| Storage Conditions |
|
| Activity | |
| Biomarker Target | |
| Research Area | |
| Sub-category Research Area | |
| Usage |
|
| Source | |
| Source / Species |
|
You may also be interested in the following product(s)
Citations
HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway.
J Immunol . 2013 Jul 12 ; 191(4) 1567 | DOI : 10.4049/jimmunol.1300080.
- JP. Goodridge
Transduction with the antioxidant enzyme catalase protects human T Cells against oxidative stress.
J Immunol . 2008 Dec 15 ; 181(12) 8382 | DOI : 10.4049/jimmunol.181.12.8382
- T. Ando
Use of overlapping peptide mixtures as antigens for cytokine flow cytometry.
J Immunol . 2001 Sep 01 ; 255(1-2) 27 | DOI : 10.1016/s0022-1759(01)00416-1
- HT. Maecker
References
The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL
J. Virol . 1996 Nov 01 ; 70(11) 7569 | DOI : 10.1128/JVI.70.11.7569-7579.1996
- MR. Wills
- et al